Vobis 0.2mg Tablet
Marketer
Orchid Chemicals & Pharmaceuticals Ltd
Salt Composition
Voglibose (0.2mg)
Overview Vobis 0.2mg Tablet
DiaBeta 0.2mg tablets manage type 2 diabetes by regulating post-prandial hyperglycemia. Prescribed when dietary changes and other therapies prove insufficient, this medication should be taken immediately before meals. Dosage and frequency are determined individually by your physician to optimize blood glucose control. Abrupt cessation is strongly discouraged; discontinuation without medical supervision risks elevated blood sugar and potentially severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include abdominal discomfort, gas, appetite changes, constipation, and diarrhea. Report any persistent or bothersome side effects to your physician. While DiaBeta 0.2mg tablets do not independently cause hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treatment for hypoglycemic episodes requires simple glucose; sucrose is ineffective. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, or bowel inflammation (e.g., Crohn's disease or ulcerative colitis). This medicine is not recommended for pregnant or breastfeeding individuals without prior medical consultation. Full disclosure of all concurrent medications is crucial for safe administration. Excessive alcohol consumption should be avoided due to the increased hypoglycemia risk.
Primary Ingredients of Vobis 0.2mg Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Vobis 0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Vobis 0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.2mg Vobis tablet whole; do not chew, crush, or divide it. Administer on an empty stomach.
Common Side effects of Vobis 0.2mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vobis 0.2mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vobis 0.2mg tablets on an empty stomach.
How Vobis 0.2mg Tablet works:
Each Vobis 0.2mg tablet functions as an antidiabetic agent. By suppressing the activity of intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, it effectively moderates postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Combining Vobis 0.2mg Tablet and alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vobis 0.2mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Using Vobis 0.2mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Vobis 0.2mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should use Vobis 0.2mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised.
LiverCAUTION
Exercise caution when administering 0.2mg Vobis tablets to patients exhibiting severe hepatic impairment. Dosage modification for Vobis 0.2mg tablets may be necessary. Physician consultation is recommended.
What if you forget to take Vobis 0.2mg Tablet :
Omit any missed Vobis 0.2mg Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vobis 0.2mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently